# Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in Children

> **NCT06208917** · PHASE3 · RECRUITING · sponsor: **Yizhuo Zhang** · enrollment: 376 (estimated)

## Conditions studied

- Pediatric Solid Tumor, Unspecified, Protocol Specific

## Interventions

- **DRUG:** Ondansetron (Oral soluble film OR injections) ,Dexamethasone

## Key facts

- **NCT ID:** NCT06208917
- **Lead sponsor:** Yizhuo Zhang
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-09
- **Primary completion:** 2026-07-01
- **Final completion:** 2027-01-31
- **Target enrollment:** 376 (ESTIMATED)
- **Last updated:** 2024-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06208917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06208917, "Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in Children". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06208917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*